Navigation Links
Mettler-Toledo International Inc. Reports Third Quarter 2009 Results
Date:10/29/2009

prior-year amount of $76.5 million. Adjusted operating income is a non-GAAP measure, and a reconciliation to earnings before taxes is provided in the attached schedules.

Cash flow from operations was $79.6 million, compared with $76.6 million in 2008.

Nine-Month Results

EPS was $3.02, compared with the prior-year amount of $3.96. Adjusted EPS was $3.48, compared with the prior-year amount of $3.85.

Sales were $1.217 billion, compared with $1.464 billion in 2008, reflecting a 12% decline in local currency sales. Reported sales declined by 17% due to a negative 5% currency impact. By region, local currency sales decreased 15% in Europe, 13% in the Americas and 4% in Asia / Rest of World. Adjusted operating income amounted to $187.2 million, an 11% decrease from the prior-year amount of $210.0 million.

Cash flow from operations was $188.5 million, compared with $160.6 million in 2008.

Cost Reduction Program

Earlier in the year, the Company announced a Cost Reduction Program aimed at reducing costs by approximately $100 million annually. The Program, which is substantially completed, consisted primarily of work force reductions and other cost efficiency measures. The Company reported that the Program will meet its target. Total restructuring charges associated with the Program are expected to be $40 million, of which $34.8 million has been incurred to date.

Fourth Quarter Outlook

The Company stated that forecasting continues to be difficult given the ongoing uncertainty in the global economy. For the fourth quarter 2009, management expects a local currency sales decline in the range of -6% to -7% and Adjusted EPS in the range of $1.90 to $2.00. For the full-year 2009, this results in a local currency sales decline of approximately -10% and Adjusted EPS in the range of $5.39 to $5.50. This compares with previous full-year Adjusted
'/>"/>

SOURCE Mettler-Toledo International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
2. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
3. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. Preclinical Data on Lead MEK Inhibitor, RDEA119, to be Presented at the 2007 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
8. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
9. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
10. Survival Data for Avicenas Amyotrophic Lateral Sclerosis Drug Candidate, AL-02, to be Presented at 18th International Symposium on ALS/MND
11. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... BETHESDA, Md. , Sept. 19, 2014 ... an initiative to harmonize global post-approval changes protocols. ... level of interest in the topic expressed by industry participants ... workshop, held earlier this month in Washington, ... and EMA were on hand for the workshop. Attendees ...
(Date:9/19/2014)... Sept. 19, 2014 Kiromic, LLC, a ... Kent Hance , the former chancellor of Texas Tech ... as chancellor in July 2014, after raising $1.2 billion for ... Kent Hance , the most successful chancellor in the ... not only as an investor, but also as our new ...
(Date:9/19/2014)... Research and Markets has announced the addition of ... Mental Disorder) Market - Forecast to 2023" report to ... the human microbiome market is segmented by application, disease, product, ... to be valued as $294 million in 2019 and is ... forecast period of 2019-2023. The market is driven by growing ...
Breaking Medicine Technology:PDA Launches Effort to Harmonize Global Post-Approval Changes Protocols 2Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 2Global Human Microbiome (Diabetes, Obesity, Autoimmune, Cancer, Diarrhea, Mental Disorder) Market - Forecast to 2023 3
... ALISO VIEJO, Calif., Nov. 9 Clarient, Inc. (Nasdaq: ... oncologists and the pharmaceutical industry, today announced that it is ... New York City. , The first presentation will be made ... 1:40 pm EST on Tuesday, November 17. The conference will ...
... Care Reform Bill , Critical legislation would strengthen ... Nov. 7 Today the United States House ... strengthen Medicare for seniors and end discrimination by insurance companies ... , The Affordable Health Care for America Act ...
Cached Medicine Technology:Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2AARP Idaho Key Vote News Alert 2AARP Idaho Key Vote News Alert 3
(Date:9/19/2014)... 19, 2014) - New research published today in the ... cases could reach 6,800 in West Africa by the ... not enacted. , Arizona State University and Harvard ... rate of rise in cases significantly increased in August ... mass quarantine was put in place, indicating that the ...
(Date:9/19/2014)... Recent two-generation approaches to reducing poverty that help ... from researchers, advocates, and foundations. By combining education ... move to jobs that offer a path out ... for children, these programs aim to improve the ... a new report from the National Center for ...
(Date:9/19/2014)... Famous Vancouver company, Pro Ace Heating ... now become a one-stop-solution for heating, air conditioning, plumbing ... The company has achieved this status by providing a ... While there are many companies that provide these services ... vendor who can offer all of these services together ...
(Date:9/19/2014)... 2014 (HealthDay News) -- When it comes to firearm ... United States, while the District of Columbia has the ... decade, deaths from gun-related violence -- including murders, suicides ... States, the study revealed. Hawaii,s rate was roughly three ... spectrum, the District of Columbia had the highest rate ...
(Date:9/19/2014)... September 19, 2014 Recently, Top10BestSEOHosting.com ... announced that JustHost, IX Web Hosting and Bluehost ... , “As is known to most people, VPS ... a physical server computer into many servers, each ... running on someone’s own dedicated computer,” the manager ...
Breaking Medicine News(10 mins):Health News:Research predicts possible 6,800 new Ebola cases this month 2Health News:A two generation lens: Current state policies fail to support families with young children 2Health News:Pro Ace Now Provides Heating, Air Conditioning, Plumbing & Electrical Services under One Roof 2Health News:U.S. Gun Deaths Lowest in Hawaii, Highest in D.C. 2Health News:Top10BestSEOHosting.com: JustHost is One of the Best VPS Suppliers in 2014 2
... show injury in as little as 6 days , , ... drug Tysabri can start causing liver damage within six days ... In January, the U.S. Food and Drug Administration expanded the ... of the digestive tract. , The drug has also been ...
... in a severe form of the disorder, , , WEDNESDAY, Feb. 27 ... and a more severe form of the disease caused by one ... are the two main findings from a Massachusetts study that found ... 35 babies a year before 2003 to less than 20 babies ...
... net premiums written increase 22% over the ... comparable year-earlier quarterly results, FARMINGTON, Conn., Feb. 27 ... today announced its financial results for the fourth quarter ended,December ... http://www.newscom.com/cgi-bin/prnh/20060829/NETU014LOGO ), -- Gross premiums written for ...
... (Nasdaq: ACUR ) announced that President and Chief,Executive ... for health,reasons for an as-yet undetermined period. Mr. Reddick ... Board of Directors. At the same time,the Company announced ... Chairman of the Board. Mr. Markham has been a ...
... Targeted Synergies Sells Rights to Bystolic(TM) (Nebivolol) for $370 ... To Consider a Sale of Dey ... MYL ),today announced its financial results for the three and nine ... for the Merck,Generics acquisition, and announced a number of strategic and ...
... 2008 Nektar,Therapeutics (Nasdaq: NKTR ) announced today ... ended December 31, 2007., Revenue totaled $65.8 million ... in the fourth quarter of 2006. For the year ... million compared to,$217.7 million in 2006., Cash, cash ...
Cached Medicine News:Health News:Tysabri May Cause Liver Damage, Health Officials Say 2Health News:Newborn Screening Suggests Decline in Cystic Fibrosis 2Health News:Newborn Screening Suggests Decline in Cystic Fibrosis 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 6Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 7Health News:Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board 2Health News:Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board 3Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 2Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 3Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 4Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 5Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 6Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 7Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 8Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 9Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 10Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 11Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 12Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 13Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 14Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 15Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 2Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 3Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 4Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 5Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 6Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 7Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 8Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 9
Viscoelastic Cannula, 23 g. Angled. 7 mm angled tip cannula with unique hub that facilitates flow of viscoelastic material. Overall length 23 mm. 5/box....
Anterior Chamber Needle, 27 g. Angled. 5 mm angled tip. Overall length 20 mm. 5/box....
Nucleus Hydrodissection Cannula, 25 g. Angled with flattened tip. 7 mm angled shaft with flattened tip for insertion under the capsular flap. Overall length 19 mm. 5/box....
Hydrodissection / Aspiration Cannula, 25 g. Angled with left hook. 10 mm angled shaft with 2.5 mm left hook tip. Overall length 20 mm. 5/box....
Medicine Products: